Orion Berg

Advising a major French bank on antitrust aspects of a partnership in the area of investment and commercial banking;

Advising BC Partners on merger control aspects in relation to the acquisition of DSO by MCS (NPL market);

Advising Eren Renewable Energy on merger control aspects in relation to its combination with Total and in the context of several investments projects in Europe and South America ;

Assisting and representing Mercedes-Benz France (Daimler AG) in a successful ruling before the French Conseil d'Etat in relation to the registration of several car models and on gaz emission follow-up issues ;

Regular assistance of EU and non EU foreign investors before the French Ministry of Economy to obtain comfort/clearance under FIC rules (notably in IT sector, network industries, pharma and public health)

Assisting a social media network and a leading instant messaging service provider in relation to the challenge of their terms of use by the French consumer protection agency including litigation before French administrative courts;

Advising a consortium of investors led by Amundi Immobilier and including Predica, Spirica and Primonial REIM, on merger control aspects in relation to the acquisition of Europe's largest office complex, 'Coeur Défense', owned by the American fund Lone Star;

Advising Basalt Infrastructure Partners LP on merger control aspects in relation to its agreement to acquire 100 percent of the ownership interest in Comax France S.A.S. from independent US power producer Maxim Power Corp.;

Advising Eurazeo SA, one of the largest European listed investment companies, on merger control aspects in relation to the acquisition from Mondelez International of certain assets in the confectionery products business, including notably a portfolio of local heritage confectionary brands (Poulain, Carambar, Krema, La Pie Qui Chante and Terry's) and 5 plants located in France;

Advising Shenzhen Hepalink Pharmaceutical Co. Ltd, a Chinese pharmaceutical company, and its US subsidiary Hepalink USA Inc. on merger control aspects in relation to the US$337.5 million acquisition of Scientific Protein Laboratories, LLC, a leading global, independent manufacturer and supplier of active pharmaceutical ingredients (APIs);

Assisting and representing an European trade association in a successful constitutional ruling before the French Conseil d'Etat in relation to the sale of food packaging containing bisphenol A (BPA);

Assisting and representing a mobile operator in proceedings before the French Competition Authority for abuse of dominant position, in particular in relation to unfair pricing issues;

Assisting a value added service operator in disputes before the French Telecoms Regulator (ARCEP); and

Regularly assisting several significant French institutional investors in the context of merger controls in the real estate sector.